Watson Pharmaceuticals searches for two new presidents

Share this article:
Watson Pharmaceuticals announced it has initiated a search for two newly created president positions for each of the Corona, Calif.-based company's business units – brands and generics.
As a result of this new management structure, Joseph Papa, Watson's chief operating officer and president, will leave the company Nov. 19.
"Following our decision in June to focus on generics and specialty brand products, including urology and nephrology, we have continued to implement strategies to increase our focus in these specialty areas," said Allen Chao, Watson's chief executive. "We believe having a president in each business unit will enhance our ability to maximize the growth of each business."
Share this article:

Email Newsletters

More in News

Gilead reaps huge HCV sales, payer fury

Gilead reaps huge HCV sales, payer fury

Sovaldi's debut has been marked by plenty of criticism from payers and lawmakers, but the hep. C drug's launch, now confirmed to be the fastest of all time, has also ...

Bayer drug gets orphan label

Bayer drug gets orphan label

The FDA designation is for an experimental, inhaled form of ciprofloxacin intended to treat a rare lung condition.

Lilly's cancer drug ramu granted gastric indication

Lilly's cancer drug ramu granted gastric indication

Ramucirumab received FDA approval today in advanced gastric cancer, a nod that could translate into $600 million in peak sales.